StockSelector.com
  Research, Select, & Monitor Friday, December 15, 2017 4:27:04 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Ligand Pharmaceuticals, Inc.$135.88($.16)(.12%)

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  Ligand Pharmaceuticals, Inc. vs Drug Manufacturers/Other

Ligand Pharmaceuticals Incorporated discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas of cancer, pain, skin diseases, men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology, primarily related to intracellular receptors.




Engaged in the discovery, development, and commercialization of innovative pharmaceuticals for the treatment of many diseases, either directly or indirectly. Directly treating a disease would involve some sort of drug that could attack the infection itself. An indirect treatment may involve a drug that's used to enhance the body's own antibody production so those antibodies can attack the infection themselves. Not only do some of these companies develop drugs for human use, a good number of them also work on animal or plant diseases as well.
 Totals Company Industry
  Sales: $109.0 Mil $100,273.0 Mil
  Market Cap: $3,203.9 Mil $381,514.7 Mil
  Analysts Recommendation: Buy Buy

 Averages Company Industry
 Growth
  Historic Revenue: 51.5% 43.1%
  Estimated Revenue: 23.9% 72.8%
  Historic Earnings: (103.9%) (53.7%)
  Estimated Earnings: N/A (23.0%)
  Stock Price (1 Year): 26.7% 102.4%
  Cash per Share: (81.6%) 8.5%
  Dividend: N/A N/A
 Price
  Trailing PE: N/A N/A
  Forward PE: 38.0 23.8
  Price-to-Sales: 24.9 N/A
  Price-to-Book: 8.3 5.9
  Dividend Yield: N/A N/A
  Market Cap: $3,203.9 Mil $12,306.9 Mil
  Operations
  Net Margin: 22.8% (286.9%)
  Gross Margin: 94.9% 82.5%
  Return on Equity: (.0) (.5)
  Return on Assets: (.0) (.3)
  Balance Sheet
  Current Ratio: .7 6.0
  Quick Ratio: .7 5.8
  Cash Ratio: .6 5.1
  Debt-to-Equity: .8 4.1
  Interest Coverage: (1.9) 2.1
 Technicals
  Relative-Strength Index: 48.7 N/A

 Other companies in Drug Manufacturers/Other Price Market Cap
  Novo Nordisk A\/S  (NVO) $52.86 $130,532.5 Mil
  UBS AG  (UBS) $18.04 $69,236.5 Mil
  Allergan plc  (AGN) $170.94 $57,008.5 Mil
  Vertex Pharmaceuticals Inc.  (VRTX) $142.53 $35,670.7 Mil
  Alexion Pharmaceuticals, Inc.  (ALXN) $113.09 $25,445.3 Mil






Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2017 StockSelector.com. All rights reserved.